Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Trésorerie et équivalents de trésorerie à 122,1 millions d’euros et dépôts à court terme1 à 24,6 millions d’euros au 30 juin 2025Produit brut de 115,6 millions d’euros reçu au titre de la deuxième...
-
First data on treatment of NPC1 with Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) in this age group over a period of 48 weeks At 48 weeks of the sub-study, 7 of 9 patients1 showed stabilization...
-
NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today that its subsidiary Cyclo Therapeutics has had two abstracts selected for...
-
Shelton, CT, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Hubbell to Acquire DMC Power Provider of connectors and tooling for utility substation and transmission marketsComplementary technology enhances...
-
Second quarter sales were $155.5 millionNet income attributable to DMC was $0.1 millionAdjusted net income attributable to DMC* was $2.5 million, or $0.12 per diluted shareAdjusted EBITDA attributable...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In DMC Global (BOOM) To Contact Him Directly To Discuss Their Options If you purchased or...
-
BROOMFIELD, Colo., July 22, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) will announce its 2025 second quarter financial results after the stock market closes on Tuesday, August 5, 2025....
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In DMC Global (BOOM) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "U.S. MICE Market Size, Share & Trends Analysis Report By Event (Meetings, Incentives, Conferences, Exhibitions), By Booking Mode (Direct Booking,...
-
NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled...